StockNews.AISignal intelligence
Company intelligence

KKR

KKR & Co. Inc. · NYSE · Financial Services

Price$106.43+0.02% · +$0.02
Market cap95.56BEquity value
P / E20.9Trailing ratio
Volume4.37MLatest session
Market data

KKR price chart

TradingView
Related signals
1 min delayed

Browse public KKR signals with their source context and measured market impact. Open any signal for its permanent analysis page.

KKRAug 31, 2026-2.29% since signal

KKR to Monetize USI for $17B, Delivering ~$2.00 ANI Per Share

KKR will sell USI Insurance Services to Aon for $17 billion in an all-cash transaction, targeting Q4 2026 closing. The deal would provide approximately $3.3 billion of after-tax proceeds and about $2.00 per share of ANI to KKR, underscoring the strong monetization track record of its Strategic Holdings portfolio and the durable cash flows within USI.

View signal analysis
KKRAug 19, 2026+3.05% since signal

KKR Becomes Preferred Bidder for Avisena Healthcare Minority Stake in Malaysia

KKR has emerged as the preferred bidder to acquire a minority stake in Avisena Healthcare, valuing the business at roughly 1.5 billion ringgit ($370 million). The potential investment underlines KKR's push into APAC healthcare and could extend its Malaysian footprint if closed. Terms and timing are not disclosed, and the transaction remains subject to due diligence and regulatory approvals.

View signal analysis
KKRAug 11, 2026+5.88% since signal

KKR-Backed LEAP India IPO Subscribed on Final Day, Signals Strong Demand

KKR-backed LEAP India's $260 million IPO was fully subscribed by midday on the final bidding day, led by non-institutional investors. The strong retail and non-institutional demand underscores appetite for tech-focused platforms in India and may help KKR diversify its exits and capital deployment in the region. The result could bolster KKR's India venture credibility and attract follow-on capital.

View signal analysis
KKRAug 6, 2026-2.18% since signal

KKR to acquire Medicover India's hospital network, signaling long-term India healthcare bet

KKR announced definitive agreements to acquire Medicover India's hospital operations from Medicover AB, marking a strategic expansion of its healthcare platform in India. The deal, still subject to regulatory approvals, leverages Medicover India's 24-hospital footprint with ~4,800 beds and 1,900 doctors across 80+ specialties. KKR frames the investment as boosting talent, technology, infrastructure, and governance to improve patient care and access over the long term.

View signal analysis
KKRAug 5, 2026-2.18% since signal

Accell Insolvency Highlights Liquidity Stress; Possible KKR Exposure Implications

Dutch bike maker Accell Group has begun insolvency proceedings after failing to meet financial obligations amid a prolonged downturn in Europe’s bike market. The move raises liquidity concerns and could trigger creditor-led restructuring or asset sales. If KKR holds an Accell stake or debt, impairment risk could affect PE portfolio valuations; otherwise the impact is more indirect.

View signal analysis
Research

Company intelligence